Condition: Atrial Fibrillation · Atrial Appendage · Anticoagulants · Sponsor: University Hospital, Bordeaux
The APPENDAGE study is a phase 4 multicentre randomized opened clinical trial comparing 2 different antithrombotic strategies following left atrial appendage closure (LAAC) in patients with non valvular atrial fibrillation (AF). The primary objective of the study is to evaluate the efficacy of Aspirin versus Aspirin + Clopidogrel after LAAC by comparing the occurrence of ischemic lesions on cerebrovascular magnetic resonance imaging (MRI) studies.
This description comes directly from the study's public registry record.
Zakaria JALAL, MD · (0)5 57 65 64 65 · zakaria.jalal@chu-bordeaux.fr
Amandine RUISSEL · (0)5 57 62 32 29 · amandine.ruissel@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| Bordeaux University Hospital | Pessac, France | Recruiting |
| Toulouse University Hospital | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04796714